Ex-vivo expansion of NK cells: What is the priority - high yield or high purity?

被引:20
作者
Berg, Maria [1 ]
Childs, Richard [1 ]
机构
[1] Natl Inst Hlth, Bethesda, MD 20892 USA
关键词
CANCER;
D O I
10.3109/14653249.2010.536216
中图分类号
Q813 [细胞工程];
学科分类号
摘要
引用
收藏
页码:969 / 970
页数:2
相关论文
共 7 条
[1]   Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells [J].
Berg, Maria ;
Lundqvist, Andreas ;
McCoy, Philip, Jr. ;
Samsel, Leigh ;
Fan, Yong ;
Tawab, Abdul ;
Childs, Richard .
CYTOTHERAPY, 2009, 11 (03) :341-355
[2]   Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells [J].
Imai, C ;
Iwamoto, S ;
Campana, D .
BLOOD, 2005, 106 (01) :376-383
[3]   Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors [J].
Lundqvist, Andreas ;
McCoy, J. Philip ;
Samsel, Leigh ;
Childs, Richard .
BLOOD, 2007, 109 (08) :3603-3606
[4]   Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer [J].
Miller, JS ;
Soignier, Y ;
Panoskaltsis-Mortari, A ;
McNearney, SA ;
Yun, GH ;
Fautsch, SK ;
McKenna, D ;
Le, C ;
Defor, TE ;
Burns, LJ ;
Orchard, PJ ;
Blazar, BR ;
Wagner, JE ;
Slungaard, A ;
Weisdorf, DJ ;
Okazaki, IJ ;
McGlave, PB .
BLOOD, 2005, 105 (08) :3051-3057
[5]  
SMITH A, 2010, ADOPTIVE TR IN PRESS
[6]   Natural killer cell-based immunotherapy in cancer: current insights and future prospects [J].
Sutlu, T. ;
Alici, E. .
JOURNAL OF INTERNAL MEDICINE, 2009, 266 (02) :154-181
[7]   Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor [J].
Sutlu, Tolga ;
Stellan, Birgitta ;
Gilljam, Mari ;
Quezada, Hernan Concha ;
Nahi, Hareth ;
Gahrton, Gosta ;
Alici, Evren .
CYTOTHERAPY, 2010, 12 (08) :1044-1055